Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Aug 31, 2025 | (Q1)May 31, 2025 | (FY)Feb 28, 2025 | (Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | (Q2)Aug 31, 2023 | (Q1)May 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | -98.22%1.71K | -97.62%887 | -93.89%827 | -43.73%96.34K | -79.60%7.49K | 1.40%38.03K | 8.72%37.28K | -78.41%13.54K |
| Operating revenue | --0 | --0 | -98.22%1.71K | -97.62%887 | -93.89%827 | -43.73%96.34K | -79.60%7.49K | 1.40%38.03K | 8.72%37.28K | -78.41%13.54K |
| Cost of revenue | 0 | 0 | -99.44%161 | -99.68%62 | 0 | -77.09%28.95K | -96.37%1.97K | -95.31%836 | -8.78%19.6K | -80.00%6.55K |
| Gross profit | 0 | 0 | -97.70%1.55K | -95.34%825 | -88.17%827 | 50.27%67.39K | 131.24%5.51K | 88.97%37.2K | 38.04%17.69K | -76.69%6.99K |
| Operating expense | -76.54%48.53K | -82.40%36.38K | 22.33%639.51K | 257.89%206.87K | 246.96%206.71K | -59.56%522.77K | -25.83%388.42K | -1.71%207.8K | -150.21%-131.02K | -79.94%59.58K |
| Selling and administrative expenses | -12.61%39.78K | -38.55%30.44K | 74.88%151.5K | 126.44%45.51K | 76.19%49.54K | -86.60%86.63K | -91.36%35.5K | 95.00%197.17K | -352.29%-172.15K | -57.60%28.12K |
| -Selling and marketing expense | -26.38%5.44K | 54.34%8.12K | 113.64%22.16K | 103.66%7.39K | -67.40%5.26K | -131.07%-162.44K | -98.61%4.8K | -77.59%18.46K | -485.20%-201.83K | -62.39%16.13K |
| -General and administrative expense | -9.93%34.34K | -49.58%22.32K | -48.07%129.33K | 28.44%38.12K | 269.35%44.28K | 101.18%249.07K | -53.35%30.69K | 853.43%178.71K | 87.39%29.68K | -48.82%11.99K |
| Research and development costs | -99.82%30 | -72.71%10.99K | -39.36%88.67K | -31.98%16.31K | 107.25%40.29K | -42.56%146.22K | 112.02%62.71K | 143.53%40.1K | -71.77%23.98K | -84.28%19.44K |
| Depreciation amortization depletion | -2.89%471 | -13.74%471 | -10.28%1.96K | -1.42%485 | 14.95%546 | -0.82%2.19K | 24.42%591 | 5.52%631 | -26.68%492 | -13.95%475 |
| -Depreciation and amortization | -2.89%471 | -13.74%471 | -10.28%1.96K | -1.42%485 | 14.95%546 | -0.82%2.19K | 24.42%591 | 5.52%631 | -26.68%492 | -13.95%475 |
| Other operating expenses | -94.29%8.25K | -104.74%-5.52K | 38.11%397.38K | 767.81%144.57K | 907.43%116.34K | -26.05%287.73K | 250.58%289.62K | -132.28%-30.1K | -84.45%16.66K | -89.15%11.55K |
| Operating profit | 76.45%-48.53K | 82.33%-36.38K | -40.09%-637.96K | -238.56%-206.05K | -291.51%-205.88K | 63.50%-455.38K | 29.26%-382.91K | 11.02%-170.6K | 159.93%148.71K | 80.30%-52.59K |
| Net non-operating interest income (expenses) | -69.10%1.92K | -65.40%2.26K | 3.02%23.64K | 15.40%6.2K | 13.63%6.53K | 47.94%22.94K | -14.68%4.81K | 24.02%7.01K | 66.36%5.38K | 481.98%5.75K |
| Non-operating interest income | -60.24%2.54K | -60.33%2.84K | -3.90%23.64K | 16.54%6.38K | 24.45%7.16K | 41.52%24.59K | 9.48%6.16K | 21.89%7.34K | 36.24%5.47K | 234.89%5.75K |
| Non-operating interest expense | 259.30%618 | -7.07%578 | ---- | 81.05%172 | --622 | -11.76%1.65K | 9,721.43%1.35K | -10.48%333 | -87.88%95 | ---- |
| Other net income (expenses) | 108.42%143 | 9,495.13%59.85K | -188.64%-1.83K | -554.28%-1.7K | -724.51%-637 | -102.68%-1.07K | 791.34%2.06K | 374 | ||
| Gain on sale of security | ---- | 108.42%143 | -80.85%-1.15K | -3,193.22%-1.83K | -554.28%-1.7K | -724.51%-637 | -729.46%-1.07K | ---- | -74.46%59 | --374 |
| Special income (charges) | ---- | ---- | --61K | ---- | ---- | --0 | --0 | --0 | --2K | ---- |
| -Less:Restructuring and mergern&acquisition | ---- | ---- | --56K | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---2K | ---- |
| -Less:Write off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| -Gain on sale of business | ---- | ---- | --117K | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Income before tax | 76.89%-46.61K | 83.10%-33.98K | -28.03%-554.48K | -229.15%-201.67K | -332.71%-201.05K | 64.85%-433.08K | 23.53%-379.17K | 27.64%-163.59K | 163.81%156.15K | 82.53%-46.46K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 76.89%-46.61K | 83.10%-33.98K | -28.03%-554.48K | -229.15%-201.67K | -332.71%-201.05K | 64.85%-433.08K | 23.53%-379.17K | 27.64%-163.59K | 163.81%156.15K | 82.53%-46.46K |
| Net income continuous operations | 76.89%-46.61K | 83.10%-33.98K | -28.03%-554.48K | -229.15%-201.67K | -332.71%-201.05K | 64.85%-433.08K | 23.53%-379.17K | 27.64%-163.59K | 163.81%156.15K | 82.53%-46.46K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 76.89%-46.61K | 83.10%-33.98K | -28.03%-554.48K | -229.15%-201.67K | -332.71%-201.05K | 64.85%-433.08K | 23.53%-379.17K | 27.64%-163.59K | 163.81%156.15K | 82.53%-46.46K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 76.89%-46.61K | 83.10%-33.98K | -28.03%-554.48K | -229.15%-201.67K | -332.71%-201.05K | 64.85%-433.08K | 23.53%-379.17K | 27.64%-163.59K | 163.81%156.15K | 82.53%-46.46K |
| Diluted earnings per share | 0 | 0 | -0.01 | 0 | 0 | 0 | 27.84%-0.0092 | 31.73%-0.004 | 140.33%0.004 | 88.00%-0.0012 |
| Basic earnings per share | 0 | 0 | -0.01 | 0 | 0 | 0 | 27.84%-0.0092 | 31.73%-0.004 | 140.33%0.004 | 88.00%-0.0012 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.